Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Hotel Consultants (EU)

Council Members in this Study Group: 91

This study group may include experts knowledgeable on topics such as automotive manufacturing and dealerships, after market distribution, alcoholic and non-alcoholic beverages, convenience stores, supermarkets, packaged goods manufacturing, department stores and discounters, jewelry and cosmetics, hotels and resorts, restaurants, casinos, and the travel industry, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Keith Allen, Director, Cardiothoracic Vascular Surgery Research, Mid America Heart & Lung Surgeons, PCKeith Allen

Director, Cardiothoracic Vascular Surgery Research
Mid America Heart & Lung Surgeons, PC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Keith Allen, MD, is a Director of Cardiothoracic-Vascular Surgery Research at the Mid America Heart Institute in Kansas City, Missouri. He is board certified in Thoracic, Vascular, and General Surgery. Dr. Allen maintains an active clinical research department...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Drug Eluting Stents:The Next Vioxx

December 14, 2006

Trading restenosis for Thrombosis? New questions about drug-eluding stents. | content.nejm.org

1. DES whether used on or off label will likely require life long anticoagulation with Plavix like drugs.

2. The incidence of late thrombosis is significant when anticoagulation is interrupted for events such as elective surgery.

3. Unlike restenosis following insertion of a bare metal stent which rarely results in death to the patient, late thrombosis following use of a DES results in a 50% mortality.

4.  Hints of this problem were present during FDA presentations prior to DES approval which may lead to significant liability as this problem becomes more apparent.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Hotel Consultancy
  • Hotels - Site

Members in this Study Group often have these job titles:

  • Director
  • Owner
  • Consultant
  • Managing Director
  • Chief Executive Officer
  • Partner
  • General Manager
  • Principal
  • President